Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12,332 GBX | +0.55% | +1.45% | +16.34% |
05-08 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
05-08 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.34% | 238B | |
+32.30% | 698B | |
+26.51% | 568B | |
-4.63% | 358B | |
+19.01% | 328B | |
+3.68% | 283B | |
+6.68% | 203B | |
-9.08% | 198B | |
+7.90% | 165B | |
-3.33% | 160B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- Fusion Pharmaceuticals Downgraded by RBC to Sector Perform From Outperform, Speculative Risk Removed, Price Target Raised to $21 From $16